Oral therapy for type 1 diabetes mellitus using a novel immunomodulator, FTY720 (fingolimod), in combination with sitagliptin, a dipeptidyl peptidase‐4 inhibitor, examined in non‐o...

por Tsuji, Takumi, Yoshida, Yuya, Fujita, Tetsuro, Kohno, Takeyuki
Publicado 2012

Renin-angiotensin system inhibitors combined with cisplatin exacerbate cisplatin-induced nephrotoxicity in mice

por Tsuji, Takumi, Hosoda, Atsuki, Toriyama, Yuuki, Yoshida, Yuya, Kohno, Takeyuki
Publicado 2022

Therapeutic approach for type 1 diabetes mellitus using the novel immunomodulator FTY720 (fingolimod) in combination with once‐daily injection of insulin glargine in non‐obese diab...

por Tsuji, Takumi, Inoue, Mariko, Yoshida, Yuya, Fujita, Tetsuro, Kaino, Yukikazu, Kohno, Takeyuki
Publicado 2011

Intravenous lipid emulsion therapy for acute clomipramine intoxication in rats

por Tsuji, Takumi, Hattori, Yuji, Komori, Koji, Yoshida, Yuya, Banno, Rie, Kohno, Takeyuki
Publicado 2018

Combination treatment with fingolimod and a pathogenic antigen prevents relapse of glucose‐6‐phosphate isomerase peptide‐induced arthritis

por Yoshida, Yuya, Mikami, Norihisa, Matsushima, Yuki, Miyawaki, Mai, Endo, Hiroki, Banno, Rie, Tsuji, Takumi, Fujita, Tetsuro, Kohno, Takeyuki
Publicado 2016